The fully automated Idylla™ ctEGFR Mutation Assay (RUO), fast and easy to perform, can be used to determine the EGFR mutation status using liquid biopsy plasma samples. Idylla™ ctEGFR covers 49 EGFR mutations in exons 18, 19, 20 & 21 and showed high concordance compared to NGS.1
For Research Use Only (RUO), not for use in diagnostic procedures.
For more information on the PlexZyme and PlexPrime licenses, click here.
Reijans et al.; ESMO poster 2019
Specimen requirements
One of the biggest challenges in oncology biomarker testing is the ability to obtain samples of sufficient size and quality. With the IdyllaTM System only a minimal amount of sample is needed
- 2 ml plasma collected using EDTA tubes
NOTE:
K2EDTA tubes: process within 4 hours
The opinions and conclusions expressed in the following publications are those of the individual authors and do not necessarily reflect the views and opinions of Biocartis and/or its employees.
